AC8
Click for more information
0.00% 4.0¢ auscann group holdings ltd

I think you have missed the point.. Their focus is not on sales...

  1. jigjigwhip
    227 Posts.
    lightbulb Created with Sketch. 46
    clock Created with Sketch.
    29/10/21
    09:53
    Post #: 57168814
    I think you have missed the point.. Their focus is not on sales in the sas market, but on products for drug approvals where income can be much higher. And by the looks of the cost of sales in quarterly reports vs income for most cannabis companies so far, i'd say its a good decision..
    AC8 Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.62M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AC8 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.